Vertex Pharmaceuticals Ownership | Who Owns Vertex Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Vertex Pharmaceuticals Ownership Summary


Vertex Pharmaceuticals is owned by 93.55% institutional investors, 0.14% insiders, and 6.30% retail investors. Capital world investors is the largest institutional shareholder, holding 11.19% of VRTX shares. American Funds Growth Fund of Amer A is the top mutual fund, with 4.72% of its assets in Vertex Pharmaceuticals shares.

VRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVertex Pharmaceuticals93.55%0.14%6.30%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Capital world investors28.73M11.19%$12.79B
Vanguard group23.26M9.01%$9.37B
Blackrock funding, inc. /de21.87M8.52%$9.74B
Blackrock21.31M8.25%$9.99B
Capital research global investors16.11M6.28%$7.17B
State street11.73M4.54%$5.50B
Fmr9.22M3.57%$3.71B
Jpmorgan chase6.31M2.45%$2.54B
Jennison associates6.15M2.40%$2.74B
Wellington management group llp5.92M2.29%$2.38B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Kynam capital management, lp330.00K11.93%$154.68M
Provident investment management155.07K5.96%$62.45M
Bridger management18.78K4.93%$8.36M
Montchanin asset management10.74K4.76%$5.03M
Healthinvest partners ab24.33K4.64%$10.83M
Bellevue group441.61K4.33%$196.60M
Edgewood management2.45M3.47%$1.09B
Rhenman & partners asset management ab61.45K3.46%$27.36M
Aimz investment advisors21.11K2.95%$8.50M
Birch hill investment advisors148.31K2.93%$66.03M

Top Buyers

HolderShares% AssetsChange
Norges bank3.41M0.18%3.41M
Capital investors2.64M0.20%1.99M
Parnassus investments1.82M1.62%1.82M
Capital research global investors16.11M1.44%1.57M
Wellington management group llp5.92M0.44%1.12M

Top Sellers

HolderShares% AssetsChange
Alliancebernstein3.92M0.54%-3.45M
Amundi1.13M0.18%-1.97M
Fmr9.22M0.22%-1.31M
Massachusetts financial services co /ma/1.28M0.18%-740.55K
Blackrock21.31M0.23%-648.44K

New Positions

HolderShares% AssetsChangeValue
Norges bank3.41M0.18%3.41M$1.37B
Parnassus investments1.82M1.62%1.82M$731.28M
Fjarde ap-fonden (the fourth swedish national pensionfund)71.19K0.38%71.19K$33.37M
Gradient investments38.01K0.31%38.01K$16.92M
Steel peak wealth management22.59K0.39%22.59K$10.06M

Sold Out

HolderChange
Perkins coie trust-1.00
Mcclarren financial advisors-1.00
Mine & arao wealth creation & management, llc.-1.00
Ruedi wealth management-1.00
Tfo-tdc-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251,575-5.06%240,147,0121.70%931.11%716-14.86%5994.90%
Mar 31, 20251,6401.74%235,693,425-0.06%911.09%82911.42%567-7.35%
Dec 31, 20241,444-9.69%218,148,736-5.74%841.05%664-9.78%543-5.89%
Sep 30, 20241,575-1.25%231,077,223-1.65%891.08%726-11.68%56810.29%
Jun 30, 20241,5701.88%234,312,9101.05%901.13%8135.31%505-1.17%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds Growth Fund of Amer A12.13M4.72%790.12K
Capital Group Growth Fnd of Amer Comp12.13M4.72%790.12K
Vanguard US Total Market Shares ETF8.18M3.19%16.09K
Vanguard Total Stock Mkt Idx Inv8.07M3.15%-186.29K
Vanguard Institutional 500 Index Trust7.30M2.84%51.91K
Vanguard 500 Index Investor6.36M2.48%-931.08K
Invesco QQQ Trust5.27M2.05%-3.30K
American Funds American Balanced A4.93M1.92%-
Capital Group New Perspective Comp4.56M1.78%538.65K
American Funds New Perspective A4.56M1.78%538.65K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 27, 2025Bhatia Sangeeta N.-Sell$102.86K
Aug 06, 2025Kewalramani Reshma CEO & PresidentBuy$1.67M
Aug 06, 2025Kewalramani Reshma CEO & PresidentBuy$2.23M
Aug 06, 2025SACHS BRUCE I-Buy$1.31M
Aug 06, 2025SACHS BRUCE I-Buy$636.21K

Insider Transactions Trends


DateBuySell
2025 Q341
2025 Q2-2
2025 Q1-21
2024 Q4-4
2024 Q3-9

VRTX Ownership FAQ


Who Owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals shareholders are primarily institutional investors at 93.55%, followed by 0.14% insiders and 6.31% retail investors. The average institutional ownership in Vertex Pharmaceuticals's industry, Biotech Stocks , is 306.59%, which Vertex Pharmaceuticals falls below.

Who owns the most shares of Vertex Pharmaceuticals?

Vertex Pharmaceuticals’s largest shareholders are Capital world investors (28.73M shares, 11.19%), Vanguard group (23.26M shares, 9.01%), and Blackrock funding, inc. /de (21.87M shares, 8.52%). Together, they hold 28.73% of Vertex Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vertex Pharmaceuticals?

Yes, BlackRock owns 8.25% of Vertex Pharmaceuticals, totaling 21.31M shares as of Jun 2024. This represents 0.23% of BlackRock's total assets, with a market value of 9.99B$. In the last quarter, BlackRock decreased its holdings by -648K shares, a -2.95% change.

Who is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 11.93% of its assets in 330K Vertex Pharmaceuticals shares, valued at 154.68M$.

Who is the top mutual fund holder of Vertex Pharmaceuticals shares?

American Funds Growth Fund of Amer A is the top mutual fund holder of Vertex Pharmaceuticals shares, with 4.72% of its total shares outstanding invested in 12.13M Vertex Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools